MARABETI, Maria Rita
MARABETI, Maria Rita
Dipartimento Biomedico di Medicina Interna e specialistica (attivo dal 01/01/2000 al 31/12/2012)
A combined determination of circulating gelatinases and inflammatory markers in breast cancer patients during therapeutic treatment
2008-01-01 MARABETI MR; DI CARA G; CANCEMI P; ALBANESE NN; COSTANTINI F; TAORMINA P; MARRAZZO A; PUCCI-MINAFRA I
Analisi comparativa tra linee cellulari di carcinoma tiroideo papillare ed anaplastico
2013-01-01 Musso, R; Di Cara, G; Albanese, NN; Marabeti, MR; Cancemi, P; Martini, D; Orsini, E; Giordano, C ; Pucci, I
Anti-oncogenic role of decorin: identification of new markers.
2009-01-01 DI CARA G; MINAFRA L; CANCEMI P; ALBANESE NN; MARABETI MR; FEO S; PUCCI, I
AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH
2011-01-01 Cancemi, P; Albanese, NN; Di Cara, G; Marabeti, MR; Musso, R; Roz, E; Lupo, C; Pucci, I
Breast cancer cells exhibit selective modulation induced by different collagen substrates.
2008-01-01 Pucci, I.; Albanese, N.; DI CARA, G.; Minafra, L.; Marabeti, M.; Cancemi, P.
Breast cancer proteomics: from research to clinical applications.
2008-01-01 PUCCI-MINAFRA I; CANCEMI P; ALBANESE NN; DI CARA G; MARABETI MR; MARRAZZO A; MINAFRA S
CIRCULATING AND TISSUE FORMS OF MMP2 AND MMP9 IN BREAST CANCER PROGRESSION
2010-01-01 Marabeti, MR; Cancemi, P; Pivetti, A; Di Cara, G; Albanese, NN; Costantini, F; Musso, R; Pucci, I
Circulating levels of Matrix Metalloproteinases (MMP-2 and MMP-9), CRP and IL-6 during therapeutic treatment of patients with breast cancer
2008-01-01 MARABETI MR; DI CARA G; CANCEMI P; ALBANESE NN; TAORMINA P; MARRAZZO A; PUCCI-MINAFRA I
Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer
2009-01-01 Marabeti, MR; Cancemi, P; Albanese, NN; Di Cara, G; Costantini, F; Musso, R; Roz, E; Lupo, C; Marrazzo, A; Pucci, I
Comparative detection of matrix metalloproteinase-2 and -9, interleukin-6 and c-reactive protein in breast cancer serum of patients during neoadjuvant chemotherapy
2007-01-01 Marabeti, M.; Cancemi, P.; DI CARA, G.; Albanese, N.; Taormina, P.; Marrazzo, A.; Pucci, I.
COMPARATIVE PROTEOMIC PROFILING OF NORMAL AND BREAST CANCER CELLS UNDER HYPOXIC CONDITIONS
2010-01-01 ALBANESE, NN; DI CARA, G; MUSSO, R; CANCEMI, P; COSTANTINI, F; MARABETI, MR; FILIPPI, I; CARRARO, F; PUCCI, I
Comparative proteomics of breast cancer surgical tissues
2009-01-01 Albanese, NN; Di Cara, G; Costantini, F; Musso, R; Marabeti, MR; Marrazzo, A; Minafra, S; Pucci, I; Cancemi, P
Correlation between MMPS and proteomic profiles of breast cancer tissues
2009-01-01 Marabeti, MR; Cancemi, P; Pivetti, A; Marrazzo, A; Taormina, P; Pucci, I
Cross-talk between breast cancer cells and fibroblasts in coculture system.
2005-01-01 Cancemi, P.; Marabeti, M.; Albanese, N.; Caricato, S.; Minafra, S.; Pucci, I.
Cytoskeleton and Proteomic Changes Induced by Fibroblasts on Breast Cancer Cells
2007-01-01 Cancemi, P.; Albanese, N.; DI CARA, G.; Minafra, L.; Marabeti, M.; Pucci, I.
Different collagen substrates induce the expression of alternative forms of keratins and vimentin in breast cancer cells.
2005-01-01 Fontana, S.; Pucci, I.; Cancemi, P.; Marabeti, M.; Minafra, S.
Differential occurrence of S100A7 in breast cancer tissues: A proteomic-based investigation
2012-01-01 Cancemi, P.; DI CARA, G.; Albanese, N.; Costantini, F.; Marabeti, M.; Musso, R.; Riili, I.; Lupo, C.; Roz, E.; Pucci Minafra, I.
DIFFERENTIAL PROTEOMIC ANALYSIS OF THYROID CARCINOMA CELL LlNES
2011-01-01 Musso, R; Di Cara, G; Albanese, NN; Costantini, F; Pivetti, A; Marabeti, MR; Zito, G; Cancemi, P; Giordano, C; Pucci, I
Differential proteomic and phenotypic behavior of papillary and anaplastic thyroid carcinoma cell lines: an updated study
2012-01-01 Musso, R; Di Cara, G; Albanese, NN; Marabeti, MR; Cancemi, P; Giordano, C; Pucci, I
Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines.
2013-01-01 Musso, R.; DI CARA, G.; Albanese, N.; Marabeti, M.; Cancemi, P.; Martini, D.; Orsini, E.; Giordano, C.; Pucci, I.